LOS ANGELES, Feb. 26, 2019 – ImaginAb, Inc., a clinical stage immuno-oncology imaging company, announced today the appointment of Ian Wilson as Chief Executive Officer while Martyn Coombs steps down for family reasons, effective immediately. In addition, Tim Irish has joined ImaginAb’s Board of Directors as an independent non-executive Director and Jeffrey Evelhoch, Ph.D. has joined the Company’s Scientific Advisory Board.
Ian Wilson, CEO of ImaginAb said, “I am honored to take this leadership role at ImaginAb, and continue to build on the many successes we have achieved, most notably in the last two years. Our ImaginAb team extends a warm welcome to Tim and Jeff as they embark on their new Board roles. We look forward to leveraging their extensive experience within global pharmaceutical companies as we continue to expand our strategic relationships and our clinical programs.”